Filing Details
- Accession Number:
- 0001209191-23-039157
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2023-06-22 18:32:29
- Reporting Period:
- 2023-06-07
- Accepted Time:
- 2023-06-22 18:32:29
- Original Submission Date:
- 2023-06-09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1815638 | Thane Wettig | C/O Fibrogen, Inc. 409 Illinois Street San Francisco CA 94158 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-06-07 | 472 | $17.04 | 110,338 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-06-07 | 1,286 | $17.04 | 109,052 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
- Includes 2,500 shares acquired on May 15, 2023 through the Issuer's Employee Stock Purchase Plan.
Billionaire Hedge Funds
